Immunovant, Inc. (IMVT) Reports In-Line Q2 EPS

Immunovant, Inc. (NASDAQ: IMVT) reported Q2 EPS of ($0.45), in-line with the analyst estimate of ($0.45).

For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• SanDisk upgraded at JPMorgan after investor day; shares climb